The Biotechnology Innovation Organization (BIO) issued the following statement regarding President Trump’s comments today supporting biopharmaceutical innovation:
“We look forward to working with President Trump and his team to enact policies that ensure better access to and affordability of today’s medicines and the vision the President laid out in his inaugural address ‘….to free the earth from the miseries of disease, and to harness the energies, industries and technologies of tomorrow.’ The ideas the President laid out in his meeting today–policies that would cut unnecessary regulation, enforce fair trade, increase competition, support small companies’ ability to attract capital and strengthen and promote market-based solutions–are ideas that BIO has been advocating for and working to build consensus on with others in the healthcare system. They will go a long way toward ensuring that patients have affordable access to today’s innovative medicines and that our companies have the policy and regulatory environment they need to bring a new generation of breakthrough medicines to our children and grandchildren.